This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FDA Clears GE’s New Discovery IGS 740 Mobile Angiography System

Stocks in this article: GE

GE Healthcare announced today it has received Food and Drug Administration (FDA) clearance for its Discovery* IGS 740, a new rail-free mobile angiography system with a 41x41-cm detector. The Discovery IGS 740 is the first of this kind of mobile angiography system in the industry to receive FDA approval.

This new imaging system puts interventional radiologists at the center of their procedures. The rail-free design allows healthcare professionals ample access to the patient while freeing clinical teams from the constraints of fixed ceiling-mounted system rails. Its wide bore C-Arm and dedicated arm-imaging positions create ease in imaging the anatomy of interest, and full patient access from the left or right. A rotating laser continuously scans the room so the system knows where it is at all times.

By eliminating the ceiling rails, installation is simplified for flexibility in designing the room and positioning ceiling-mounted ancillaries (monitors, radshields, lights) where healthcare professionals need them.

The Discovery IGS 740 is equipped with two customizable parking positions to accommodate multiple room sizes and shapes. The 41x41-cm detector enables imaging of large organs, such as the liver and simultaneous coverage of both legs. The wide-bore C-arm helps interventional radiologists image large patients and conveniently perform off centered 3D acquisitions. In addition, the system comes equipped with more than 20 advanced applications, such as FlightPlan for Liver, which helps clinicians identify tumor-feeding vessels in a few clicks, and be selective during liver embolizations.

“Our goal is to pioneer a solution designed to free interventional radiologists from traditional constraints,” says Chantal Le Chat, General Manager of GE Healthcare Premium Angiography. “With the enhanced mobility of the Discovery IGS 740, clinicians have full freedom to operate, and we believe this can revolutionize the field of interventional imaging.”

*Trademark of General Electric Company.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,201.34 +9.97 0.06%
S&P 500 1,999.25 -2.91 -0.15%
NASDAQ 4,623.0090 -14.9850 -0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs